Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
People with Medicare Part D already receive full drug coverage, but people with only Part A or Part B may benefit from Medicaid coverage
They work by mimicking the action of naturally occurring GLP-1, a hormone produced in the intestine in response to food intake
Officially, the FDA cites: Insufficient large-scale clinical trials Concerns about consistency, sourcing, and manufacturing standards The need to meet formal drug approval requirements Critics argue (fairly) that this system: Favors large pharmaceutical companies Makes it hard to approve naturally occurring peptides Leaves promising, low-risk compounds in regulatory limbo The short version: This FDA restrictive regulatory change of mind wasnt driven by a sudden safety scare, it was driven by regulatory process and economics
EClinicalMedicine 49 , 101436 (2022)
US$ 28.91
US$ 27.81
US$ 21.23
US$ 23.60
US$ 26.38
US$ 20.86
US$ 26.22
US$ 26.56
US$ 21.86
